13 studies found for:    Alzheimer's | Open Studies | United States, Utah
Show Display Options
RSS Create an RSS feed from your search for:
Alzheimer's | Open Studies | United States, Utah
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
Condition: Alzheimer's Disease
Interventions: Drug: Solanezumab;   Drug: Placebo
2 Recruiting Efficacy and Safety of MK-7622 as Adjunct Therapy to Donepezil in Participants With Alzheimer's Disease (MK-7622-012)
Condition: Alzheimer's Disease
Interventions: Drug: MK-7622;   Drug: Placebo;   Drug: Donepezil
3 Recruiting An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738)
Condition: Alzheimer's Disease
Interventions: Drug: MK-8931 (Part I and Part II);   Drug: Placebo (Part I);   Drug: MK-8931 (Part II)
4 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: TRx0237 200 mg/day;   Drug: Placebo
5 Recruiting Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset
Condition: Mild Cognitive Impairment Due to Alzheimer's Disease
Interventions: Drug: Pioglitazone;   Drug: Pioglitazone placebo
6 Recruiting Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Drug: EVP-6124;   Drug: Placebo
7 Recruiting AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext
Condition: Alzheimer's Disease
Interventions: Drug: AC-1204;   Drug: Placebo
8 Recruiting Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients
Conditions: Agitation;   Alzheimer's Disease
Interventions: Drug: AVP-923 (dextromethorphan/quinidine);   Drug: Placebo
9 Recruiting A Study of Gantenerumab in Patients With Mild Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Drug: gantenerumab;   Drug: placebo
10 Recruiting A Study of LY3002813 in Participants With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Biological: LY3002813-IV;   Biological: LY3002183-SC;   Drug: Placebo-IV
11 Recruiting Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss
Condition: Cognition Disorders
Interventions: Drug: Solanezumab;   Drug: Placebo
12 Recruiting Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Condition: Dementia
Intervention: Procedure: FDG-PET brain scan
13 Recruiting Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Condition: Behavioral Variant Frontotemporal Dementia (bvFTD)
Interventions: Drug: TRx0237;   Drug: Placebo

Indicates status has not been verified in more than two years